Vulnerability in Gbgplc Acuant Acufill Sdk

CVE-2022-48224

An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. It is installed with insecure permissions (full write access within Program Files). Standard users can replace files within this directory that get executed with elevated privileges, leading to a complete arbitrary code execution (elevation of privileges).

Published · last modified .

CVSS v3 metric

CVSS v3 base score 7.3 (High). Vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:H.

EPSS exploit prediction

EPSS: 0.002 (10.9th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 11th percentile — 10.9% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2022-48224: held from 0.002 to 0.002.

EPSS over last 30 days · oldest: 0.002 · newest: 0.002 · change: 0.000

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2022-48224?
CVE-2022-48224 is a high-severity vulnerability in Gbgplc Acuant Acufill Sdk, classified under Uncontrolled Search Path Element. CVSS score: 7.3/10. Published 2023-04-04.
How severe is CVE-2022-48224?
High severity. CVSS v3 base score is 7.3 out of 10.